{"result": "{\n    \"title\": \"Gilles De La Tourette Syndrome and Associated Symptoms\",\n    \"summary\": \"The community focuses on Gilles De La Tourette Syndrome (GTS), a neurological disorder characterized by involuntary tics and various associated symptoms. Key entities include symptoms like chorea, dystonia, and echolalia, as well as compounds used for palliation such as olanzapine and pimozide. The relationships among these entities highlight the complexity of GTS and its management.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant challenges posed by Gilles De La Tourette Syndrome and its associated symptoms on individuals' quality of life and the healthcare system.\",\n    \"findings\": [\n        {\n            \"summary\": \"Gilles De La Tourette Syndrome as a central entity\",\n            \"explanation\": \"Gilles De La Tourette Syndrome is the primary focus of this community, characterized by involuntary tics and a range of associated symptoms. This disorder significantly impacts individuals' daily lives, leading to challenges in social interactions, education, and employment. The complexity of GTS is underscored by its association with various neurological and psychological symptoms, necessitating a comprehensive understanding of its manifestations and treatment options. [Data: Entities (186), Relationships (35, 43)]\"\n        },\n        {\n            \"summary\": \"Diverse symptoms associated with GTS\",\n            \"explanation\": \"The community encompasses a variety of symptoms associated with Gilles De La Tourette Syndrome, including chorea, dystonia, and echolalia. Each of these symptoms presents unique challenges for individuals, affecting their motor control, communication abilities, and overall quality of life. For instance, chorea involves irregular, unintentional movements, while echolalia is characterized by the involuntary repetition of phrases, both of which can lead to social stigma and isolation. Understanding these symptoms is crucial for effective management and support. [Data: Entities (189, 191, 192); Relationships (487, 489, 490)]\"\n        },\n        {\n            \"summary\": \"Pharmacological interventions for GTS\",\n            \"explanation\": \"Several compounds are utilized to palliate the symptoms of Gilles De La Tourette Syndrome, including olanzapine, pimozide, and haloperidol. These medications aim to reduce the severity of tics and associated symptoms, but they may also come with side effects that need to be managed. The choice of medication often depends on the individual's specific symptoms and their response to treatment, highlighting the need for personalized medical approaches in managing GTS. [Data: Entities (202, 199, 213); Relationships (500, 499, 213)]\"\n        },\n        {\n            \"summary\": \"Neurological underpinnings of GTS\",\n            \"explanation\": \"Gilles De La Tourette Syndrome localizes within various brain structures, including the cerebellar nuclear complex and the autonomic nervous system. This localization is critical for understanding the neurological basis of the disorder and its symptoms. The involvement of these brain regions suggests that GTS may affect motor control and involuntary functions, which are essential for daily activities. Research into these neurological aspects can inform better treatment strategies and interventions. [Data: Entities (199, 200, 197); Relationships (497, 498, 495)]\"\n        },\n        {\n            \"summary\": \"Overlap with other neurological disorders\",\n            \"explanation\": \"Gilles De La Tourette Syndrome shares symptoms with other neurological disorders, such as Huntington Disease. This overlap can complicate diagnosis and treatment, as symptoms may be misattributed or misunderstood. Understanding the distinctions and similarities between GTS and other conditions is vital for healthcare providers to offer accurate diagnoses and effective treatment plans. This complexity emphasizes the importance of comprehensive assessments in clinical settings. [Data: Entities (193); Relationships (491)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n186,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome is a neurological disorder characterized by involuntary tics and other symptoms affecting the nervous system.,26\n187,AEROPHAGY,\"Aerophagy is a symptom associated with Gilles De La Tourette Syndrome, characterized by excessive swallowing of air.\",1\n200,AUTONOMIC NERVOUS SYSTEM,\"The autonomic nervous system is a part of the nervous system where Gilles De La Tourette Syndrome localizes, regulating involuntary bodily functions.\",1\n188,CATALEPSY,\"Catalepsy is a symptom associated with Gilles De La Tourette Syndrome, involving a trance-like state and muscular rigidity.\",1\n199,CEREBELLAR NUCLEAR COMPLEX,\"The cerebellar nuclear complex is a brain structure where Gilles De La Tourette Syndrome localizes, involved in coordination and balance.\",1\n189,CHOREA,\"Chorea is a symptom associated with Gilles De La Tourette Syndrome, characterized by irregular, unintentional movements.\",1\n190,\"DYKINESIA, DRUG-INDUCED\",\"Drug-induced dyskinesia is a symptom associated with Gilles De La Tourette Syndrome, resulting from medication side effects.\",1\n191,DYSTONIA,\"Dystonia is a symptom associated with Gilles De La Tourette Syndrome, involving involuntary muscle contractions.\",1\n192,ECHOLALIA,\"Echolalia is a symptom associated with Gilles De La Tourette Syndrome, characterized by the involuntary repetition of phrases or words.\",1\n193,HUNTINGTON DISEASE,Huntington Disease is a neurological disorder that can present symptoms similar to those of Gilles De La Tourette Syndrome.,1\n194,HYPERKINESIS,\"Hyperkinesis is a symptom associated with Gilles De La Tourette Syndrome, characterized by excessive movement.\",1\n195,LANGUAGE DISORDERS,\"Language disorders are symptoms associated with Gilles De La Tourette Syndrome, affecting communication abilities.\",1\n196,LEARNING DISORDERS,\"Learning disorders are symptoms associated with Gilles De La Tourette Syndrome, impacting educational performance.\",1\n197,INTERNAL CAPSULE OF TELENCEPHALON,\"The internal capsule of the telencephalon is a brain structure where Gilles De La Tourette Syndrome localizes, involved in motor control.\",1\n202,OLANZAPINE,\"Olanzapine is a compound used to palliate symptoms of Gilles De La Tourette Syndrome, with unspecified side effects.\",1\n203,MECAMYLAMINE,\"Mecamylamine is a compound used to palliate symptoms of Gilles De La Tourette Syndrome, with various side effects.\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n54,CLONIDINE,GILLES DE LA TOURETTE SYNDROME,Clonidine is used to palliate symptoms of Gilles De La Tourette Syndrome,41\n499,GILLES DE LA TOURETTE SYNDROME,PIMOZIDE,Pimozide is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n502,GILLES DE LA TOURETTE SYNDROME,RISPERIDONE,Risperidone is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n503,GILLES DE LA TOURETTE SYNDROME,PERPHENAZINE,Perphenazine is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n504,GILLES DE LA TOURETTE SYNDROME,PERGOLIDE,Pergolide is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n213,HALOPERIDOL,GILLES DE LA TOURETTE SYNDROME,Haloperidol is used to palliate symptoms of Gilles De La Tourette Syndrome,35\n505,GILLES DE LA TOURETTE SYNDROME,ZIPRASIDONE,Ziprasidone is used to palliate symptoms of Gilles De La Tourette Syndrome,34\n35,BRAIN,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome localizes at the brain,33\n43,NERVOUS SYSTEM,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome localizes at the nervous system,32\n47,CENTRAL NERVOUS SYSTEM,GILLES DE LA TOURETTE SYNDROME,Gilles De La Tourette Syndrome localizes at the central nervous system,32\n496,GILLES DE LA TOURETTE SYNDROME,MIDBRAIN,Gilles De La Tourette Syndrome localizes at the midbrain,28\n485,GILLES DE LA TOURETTE SYNDROME,AEROPHAGY,Aerophagy is a symptom presented by Gilles De La Tourette Syndrome,27\n498,GILLES DE LA TOURETTE SYNDROME,AUTONOMIC NERVOUS SYSTEM,Gilles De La Tourette Syndrome localizes at the autonomic nervous system,27\n486,GILLES DE LA TOURETTE SYNDROME,CATALEPSY,Catalepsy is a symptom presented by Gilles De La Tourette Syndrome,27\n497,GILLES DE LA TOURETTE SYNDROME,CEREBELLAR NUCLEAR COMPLEX,Gilles De La Tourette Syndrome localizes at the cerebellar nuclear complex,27\n487,GILLES DE LA TOURETTE SYNDROME,CHOREA,Chorea is a symptom presented by Gilles De La Tourette Syndrome,27\n488,GILLES DE LA TOURETTE SYNDROME,\"DYKINESIA, DRUG-INDUCED\",Drug-induced dyskinesia is a symptom presented by Gilles De La Tourette Syndrome,27\n489,GILLES DE LA TOURETTE SYNDROME,DYSTONIA,Dystonia is a symptom presented by Gilles De La Tourette Syndrome,27\n490,GILLES DE LA TOURETTE SYNDROME,ECHOLALIA,Echolalia is a symptom presented by Gilles De La Tourette Syndrome,27\n491,GILLES DE LA TOURETTE SYNDROME,HUNTINGTON DISEASE,Huntington Disease can present symptoms similar to those of Gilles De La Tourette Syndrome,27\n492,GILLES DE LA TOURETTE SYNDROME,HYPERKINESIS,Hyperkinesis is a symptom presented by Gilles De La Tourette Syndrome,27\n493,GILLES DE LA TOURETTE SYNDROME,LANGUAGE DISORDERS,Language disorders are symptoms presented by Gilles De La Tourette Syndrome,27\n494,GILLES DE LA TOURETTE SYNDROME,LEARNING DISORDERS,Learning disorders are symptoms presented by Gilles De La Tourette Syndrome,27\n495,GILLES DE LA TOURETTE SYNDROME,INTERNAL CAPSULE OF TELENCEPHALON,Gilles De La Tourette Syndrome localizes at the internal capsule of telencephalon,27\n500,GILLES DE LA TOURETTE SYNDROME,OLANZAPINE,Olanzapine is used to palliate symptoms of Gilles De La Tourette Syndrome,27\n501,GILLES DE LA TOURETTE SYNDROME,MECAMYLAMINE,Mecamylamine is used to palliate symptoms of Gilles De La Tourette Syndrome,27\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}